Potential conflict of interest: Nothing to report.
MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway
Article first published online: 1 APR 2014
© 2014 by the American Association for the Study of Liver Diseases
Volume 59, Issue 5, pages 1874–1885, May 2014
How to Cite
Yang, X., Zhang, X.-F., Lu, X., Jia, H.-L., Liang, L., Dong, Q.-Z., Ye, Q.-H. and Qin, L.-X. (2014), MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway. Hepatology, 59: 1874–1885. doi: 10.1002/hep.26941
Supported by China National Key Projects for Infectious Disease (2008ZX10002-021, 2012ZX10002-012), the National Key Basic Research Program of China (2013CB910500; 2009CB521701), Program for Changjiang Scholars and Innovative Research Team (the Ministry of Education of China; IRT1118), Program of Shanghai Chief Scientist (08XD14008), China National Natural Science Foundation (81120108016; 30600589), Program for Outstanding Medical Academic Leader (LJ10010).
- Issue published online: 23 APR 2014
- Article first published online: 1 APR 2014
- Accepted manuscript online: 21 NOV 2013 02:25AM EST
- Manuscript Accepted: 17 NOV 2013
- Manuscript Received: 9 SEP 2013
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.